Histotripsy Demystified – Feb. 25
The Life Raft Group is proud to present “Histotripsy Demystified: Truths and Misconceptions Explained,” taking place on February 25, 2026, from 12:00–1:30 PM ET.
This webinar features an expert panel moderated by Dr. Elizabeth Lilley of Brigham and Women’s Hospital with Dr. Hop Tran Cao (MD Anderson Cancer Center), Dr. Suzanne George (Dana-Farber Cancer Institute), Dr. Alicia Gingrich (University of Nevada/Renown Health System) and Dr. Jiping Wang and Dr. Chandrajit Raut (Brigham and Women’s Hospital/Harvard Medical School).
This virtual discussion is open to patient and caregivers of ALL sarcoma types.
Histotripsy is a noninvasive treatment that uses focused ultrasound to mechanically destroy targeted tissue without surgery, incisions, or radiation. The procedure has only recently moved into human clinical trials and clinical use, with the first FDA clearance for treating liver tumors granted in October 2023 and broader study and adoption continuing through the mid-2020s.
This virtual panel discussion will bring together experts from multiple institutions to share diverse perspectives on histotripsy, including how the technology works, where the science currently stands, and common myths and misconceptions. Because histotripsy is being explored across multiple tumor types, the discussion will be relevant and beneficial to all sarcoma patients seeking to better understand emerging treatment approaches and their potential future role in care. A moderated Q&A segment will follow the discussion.
These webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments, please reach out to truggiero@liferaftgroup.org
About Our Presenters:
Moderator: Dr. Elizabeth Lilley is a surgical oncologist at Brigham and Women’s Hospital specializing in the management of soft tissue sarcomas, including gastrointestinal stromal tumors (GIST), with a special focus on robotic and minimally invasive surgical techniques. Dr. Lilley is triple board certified in surgical oncology, general surgery, and palliative medicine. Her research focuses on improving the quality of surgical care for patients with metastatic and recurrent cancers by improving communication surrounding the goals and outcomes of surgery.
Dr. Lilley earned a bachelor’s degree in neuroscience from Lafayette College, a master’s of public health from Columbia University, and a medical degree from Rutgers. She completed general surgery residency at Brigham and Women’s Hospital, followed by the Harvard Interdisciplinary Palliative Care Fellowship. Upon completing fellowship training in Complex General Surgical Oncology at MD Anderson Cancer Center, she joined the faculty at Brigham and Women’s Hospital and Harvard Medical School, where she now leads a health services research program centered on the intersection of surgical oncology and palliative care. Her combined expertise in both sarcoma surgery and palliative medicine uniquely positions her to improve the person-centered care of patients with advanced sarcomas.
Dr. Suzanne George is the Division Chief of the Sarcoma Center at Dana-Farber Cancer Institute where leads a team focused on research and clinical care of patients with sarcomas and GIST. She has an extensive research experience in clinical trials and drug development and cares for patient from across New England, the US and internationally.
Dr. Alicia Gingrich is a surgical oncologist at the University of Nevada, Reno. She attended medical school at the University of Kansas prior to completing general surgery residency at the University of California, Davis. She trained at MD Anderson for her complex general surgical oncology fellowship. Dr. Gingrich’s clinical practice focuses on soft tissue sarcoma and GIST as well as hepatobiliary tumors. The University of Nevada, Reno/Renown were one of the early adopters of Histotripsy and have been performing this procedure for 2 years. She utilizes Histotripsy for select patients with liver tumors.
Dr. Chandrajit P. Raut is a dedicated surgical oncologist who specializes in the multidisciplinary care of patients with soft tissue sarcoma. He is a prolific researcher who has received federal funding to investigate sarcoma tumor genetics and identify strategies at reducing sarcoma recurrence rates. Additionally, he has served as co-PI or institutional PI on several US and international phase 2 or phase 3 clinical trials evaluating neoadjuvant or adjuvant therapies in various sarcomas.
Dr. Raut is a graduate of Stanford University, University of Oxford, and Harvard Medical School. He completed his general surgery residency at Massachusetts General Hospital and surgical oncology fellowship at M.D. Anderson Cancer Center.
Dr. Raut currently serves as Chair of the AJCC Soft Tissue Sarcoma Staging Panel (9th edition), Co-Chair of the Surgery Committee in the cancer cooperative group Alliance for Clinical Trials in Oncology, and Treasurer on the Executive Board of the Connective Tissue Oncology Society. In 2013, he co-founded the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. He is the former Program Director of the Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship Program at Harvard Medical School. He serves as Section Editor for sarcoma in the journals Cancer and Surgical Oncology Insights. He has authored over 300 papers and over 30 book chapters.
Dr. Hop Tran Cao is an Associate Professor and Vice-Chair of Clinical Operations in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, where he specializes in the management of hepatobiliary tumors. He is an expert in minimally invasive surgical techniques and chairs the Minimally Invasive and New Technology in Oncologic Surgery governing committee at MD Anderson. He also chairs the multidisciplinary Histotripsy Steering Committee.
Dr. Tran Cao’s research focuses on improving cancer care quality and precision. He completed his General Surgery residency at the University of California San Diego and his fellowship in Complex General Surgical Oncology at MD Anderson.
Dr. Jiping Wang is a surgical oncologist at Brigham and Women’s Hospital. He specializes in treating gastric, liver, and pancreatic cancer and soft tissue sarcoma. He has a special interest in using minimally invasive platforms to perform cancer surgeries. In this video he explains robotic surgery for patients.